Karan Bhalla is a Cardiology physician affiliated with Texas Medical Center. OpenAlex indexes 17 publications with 280 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5413 Crenshaw Rd
400
Pasadena, TX 775056407
Telephone
713-943-2800Provider last certified this registry record 31 Oct 2022.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202522 payments
- Medtronic, Inc.Program year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.4%Adenosine Receptor Agonist20.9%Regadenoson100%Part B, office-administered≥485 patientsBeta blocker13%Metoprolol Succinate55%Metoprolol Tartrate18%Carvedilol15%Atenolol8%Sotalol3%Propranolol Hcl Er1%Part D<11 patients+ 21 more classes in this area
Blood & clotting
15.1%Factor Xa inhibitor7.7%Eliquis60%Xarelto40%Part D≥128 patientsP2Y12 inhibitor6.4%Clopidogrel94%Prasugrel Hcl6%Part D≥217 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.3%Potassium supplement1%Potassium Chloride100%Part D≥37 patientsBiguanide (metformin)0.4%Metformin Hcl100%Part D≥17 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pulsed Field Ablation for Persistent Atrial Fibrillation
Journal of the American College of Cardiology
2025 - Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis
European Heart Journal - Imaging Methods and Practice
2023 - Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY
Journal of the American Heart Association
2022 - Next-generation Mobile Cardiac Telemetry: Clinical Value of Combining Electrocardiographic and Physiologic Parameters
Journal of Innovations in Cardiac Rhythm Management
2022
Similar KOLs
Other experts from the same institution or the same specialty.
James Fleshman, MD
Texas Medical Center
Mark Zafereo, MD
Texas Medical Center
Mihail Chelu, MD, PhD
Texas Medical Center
Anju Bhardwaj, MD
Texas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”